Investing

This pharma stock is set to surge 71% thanks to autoimmune disease treatment

The company's experimental treatment could represent a more than $20 billion opportunity.

adminadmin
Oct 4, 2024 - 05:00
 0  27
This pharma stock is set to surge 71% thanks to autoimmune disease treatment
The company's experimental treatment could represent a more than $20 billion opportunity.
Read More

Tags:

Previous Article

Citi gives its top picks for clients heading into the fourth quarter

Next Article

Helene aftermath: Here's how to avoid being a victim of post-storm scams

admin
admin

Related Posts

There's still time to reduce your 2024 tax bill with these strategies

There's still time to reduce your 2024 tax bill with th...

admin Oct 29, 2024  0  8

This ETF's 2024 gains nearly match the Nasdaq Composite — with less volatility

This ETF's 2024 gains nearly match the Nasdaq Composite...

admin Sep 6, 2024  0  11

Here's how to know if your college kid actually needs 'dorm insurance'

Here's how to know if your college kid actually needs '...

admin Sep 11, 2024  0  8